Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Department of Woman and Child, Biomedical Sciences, and Leuvens Kankerinstituut, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium (Timmerman) Department of Woman and Child, Biomedical Sciences, Leuvens Kankerinstituut, University Hospitals, and Department of Electrical Engineering, Katholieke Universiteit Leuven, Leuven, Belgium (Van Calster) Department of Woman and Child, Biomedical Sciences, and Leuvens Kankerinstituut, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium (Vergote) Department of Electrical Engineering, Katholieke Universiteit Leuven, Leuven, Belgium (Van Hoorde) Leuvens Kankerinstituut, University Hospitals Katholieke Universiteit Leuven, Leuven, Belgium, and Division of Gynecological Oncology, Department of Obstetrics and Gynecology, MUMC+, GROW-School for Oncology and Developmental Biology, Maastricht, The Netherlands (Van Gorp) Department of Obstetrics and Gynaecology, Skåne University Hospital Malmö, Lund University, Malmö, Sweden (Valentin) Department of Woman and Child, Biomedical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium, and Department of Obstetrics and Gynaecology, Imperial College London, Queen Charlotte's and Chelsea Hospital, London, United Kingdom (Bourne).
Dirk
D
Timmerman
Ben
B
Van Calster
Ignace
I
Vergote
Kirsten
K
Van Hoorde
Toon
T
Van Gorp
Lil
L
Valentin
Tom
T
Bourne
D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood* / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index
D014408:Biomarkers, Tumor